KVUE
What one share of Kenvue holds
Perfumes, Cosmetics and Other Toilet Preparations
At Kenvue, our purpose is to realize the extraordinary power of everyday care. As a global leader at the intersection of healthcare and consumer goods, we are the world’s largest pure-play consumer health company by revenue with $15.1 billion in Net sales in the fiscal year 2025.
Kenvue’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-28; the balance sheet is as of 2026-06-28.
| Sales | $8.02 |
|---|---|
| Profit | $0.86 |
| Capex (buildings and equipment) | $0.21 |
| Free cash flow | $1.00 |
| Dividends | $0.83 |
| Cash and investments | $0.58 |
| Debt | $4.42 |
| Book value | $5.50 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $8.77 | $1.21 | $0.17 | $0.02 | — | $11.94 |
| 2022 | $8.71 | $1.20 | $0.22 | $1.25 | — | $10.43 |
| 2023 | $8.35 | $0.90 | $0.25 | $1.46 | $0.40 | $5.85 |
| 2024 | $8.04 | $0.54 | $0.23 | $0.69 | $0.81 | $5.05 |
| 2025 | $7.86 | $0.76 | $0.25 | $0.90 | $0.82 | $5.62 |